Categories
All Family Health Anti Cancer Cancer Treatment Cancer Treatment & Outcomes Cancer Treatment Guidance Cancer Treatment Options Cancer Wellness Protocols Drug Repurposing & Innovation Fenbendazole Fenbendazole and Cancer Health & Wellness integrative-oncology Ivermectin Mebendazole Non-Chemo Cancer Treatments Pillar Repurposed Drugs and Cancer Research

CAC Announces New Relationship with All Family Health

Courage Against Cancer is excited to announce a new relationship with All Family Health, expanding access to convenient telehealth consultations with licensed healthcare providers. Through this new resource, individuals can request medical evaluations for prescription medications including ivermectin and mebendazole, when clinically appropriate. CAC does not prescribe or determine treatment—we connect our community with additional healthcare resources so patients can have informed conversations with qualified medical professionals about their options.

Categories
Cancer Treatment Claims & Critical Analysis Clinical Trials & Cancer Treatment Fenbendazole Non-Chemo Cancer Treatments Repurposed Drug Studies Repurposed Drugs and Cancer Research

Human Clinical Trial Evidence for Fenbendazole in Cancer as of 2026

At Courage Against Cancer (CAC), we believe every patient deserves evidence-based answers to the most pressing question behind the fenbendazole conversation: Has this compound actually been tested in human cancer clinical trials? As of 2026, the honest answer is: minimally, and with significant …

Categories
Anti Cancer cancer research Cancer Support & Encouragement Cancer Treatment Cancer Treatment Claims & Critical Analysis Cancer Treatment Guidance Cancer Wellness Protocols Drug Repurposing & Innovation Fenbendazole Fenbendazole and Cancer Health & Wellness Integrative Oncology Insights Joe Tippins Non-Chemo Cancer Treatments Repurposed Drugs and Cancer Research

What Is Fenbendazole and How Does It Work Biologically?

At Courage Against Cancer (CAC), we believe every patient deserves evidence-based answers to the pillar article’s primary question: does fenbendazole have a meaningful role in colorectal cancer care? Before that question can be answered responsibly, it helps to understand what fenbendazole actua…

Categories
Biome Health Cancer Support & Encouragement Cancer Treatment Options Cancer Wellness Protocols Faith & Inspiration Genetic Testing Genome Sequencing Gut Biome Gut-Microiome Health & Wellness Non-Chemo Cancer Treatments nutrition Wellness Blueprint

New Video: How CAC Wellness Blueprint Turns Your Test Results Into a Real Plan

A short video walking through how CAC Wellness Blueprint works — from your test kit to your results call to ongoing coaching — grounded in CAC’s own research and current national studies on genomics and the microbiome.

Categories
Anti Cancer Cancer Research & Clinical Evidence Cancer Treatment Cancer Treatment Guidance Colorectal Cancer Treatment & Research Drug Repurposing & Innovation Evaluating Cancer Treatment Claims Fenbendazole Health & Wellness Ivermectin Mebendazole Mitochondria Non-Chemo Cancer Treatments Repurposed Drugs and Cancer Research

How does fenbendazole differ from other repurposed drugs like metformin or ivermectin in colorectal cancer research?

Fenbendazole, metformin, and ivermectin target colorectal cancer through different mechanisms. Fenbendazole disrupts tubulin, metformin inhibits energy production, and ivermectin blocks drug resistance. While metformin has the strongest human evidence, none have FDA approval for cancer treatment. Ongoing research is needed, and patients should consult their oncology teams for guidance.

Categories
Anti Cancer Breakthrough Therapies Cancer Support & Encouragement Cancer Treatment Cancer Treatment & Outcomes Cancer Treatment Guidance Cancer Treratments Drug Repurposing & Innovation Fenbendazole Integrative Oncology Insights Ivermectin Mebendazole Non-Chemo Cancer Treatments Repurposed Drug Studies

Fenbendazole Dosage Guide for Humans 2026

Fenbendazole is one of the most talked-about topics in cancer communities heading into 2026 — and we’re adding our voice to the conversation. Watch our latest video where we share our take on FBZ, then grab our free downloadable dosage guideline to keep on hand.

Categories
Anti Cancer Breakthrough Therapies Cancer Research & Clinical Evidence Cancer Treatment & Clinical Research Cancer Treatment & Outcomes Cancer Treatment Claims & Critical Analysis Cancer Treatment Research & Critical Analysis Cancer Treratments Cancer Wellness Protocols Colorectal Cancer Drug Repurposing & Innovation Evaluating Cancer Treatment Claims Fenbendazole Health & Wellness Hulscher Study Integrative Oncology Insights Ivermectin Mebendazole Natural Treatments Non-Chemo Cancer Treatments Pancreatic Cancer Repurposed Drug Studies Research News & Updates Wellness Company

The Anticancer Research Expression of Concern: Data Verifiability, Statistical Reliability, and Ethical Oversight Questions Selling the Product Studied? The Wellness Company’s Commercial Role Explained

The article discusses an Expression of Concern issued by Anticancer Research regarding the Hulscher et al. study on ivermectin and mebendazole. It highlights data verifiability issues, the authors’ conflicts of interest tied to The Wellness Company, and how this study differs from credible cancer research, ultimately urging caution for patients evaluating such claims.

Categories
Anti Cancer Cancer Research Literacy Cancer Support & Encouragement Cancer Treatment Cancer Treatment Guidance Cancer Treatment Options Colorectal Cancer Critical Evaluation of Cancer Research Drug Repurposing & Innovation Evaluating Cancer Treatment Claims Fenbendazole Health & Wellness Integrative Oncology Insights Ivermectin Joe Tippins Mebendazole Natural Treatments Non-Chemo Cancer Treatments Repurposed Drug Studies

The Joe Tippens Story: How a Veterinary Dewormer Became a Viral Cancer Cure Claim

The article from Courage Against Cancer discusses Joe Tippens, whose recovery from small cell lung cancer was linked to fenbendazole, a veterinary dewormer. It emphasizes that his case lacks clinical validation and critical context, such as concurrent immunotherapy, highlighting the importance of distinguishing personal narratives from scientific evidence in cancer treatment discussions.

Categories
Anti Cancer Breakthrough Therapies cancer research Cancer Treatment & Clinical Research Cancer Treatment & Outcomes Cancer Treatment Claims & Critical Analysis Cancer Treatment Guidance Critical Evaluation of Cancer Research Evaluating Cancer Treatment Claims Health & Wellness Hulscher Study immunotherapy Ivermectin Mebendazole preclinical trial Repurposed Drug Studies Research News & Updates

What were the main findings of the Hulscher et al. 2026 ivermectin cancer study published in Anticancer Research?

Written by Sean Kimbrough, Founder & Executive Director, Courage Against CancerSourced from peer-reviewed and IRB-registered clinical research · Last updated July 14, 2026

Categories
Anti Cancer Breakthrough Therapies cancer research Cancer Support & Encouragement Cancer Treatment Cancer Treatment & Clinical Research Cancer Treatment & Outcomes Cancer Treatment Claims & Critical Analysis Cancer Treatment Guidance Cancer Treatment Options Cancer Wellness Protocols cancer-prevention chemotherapy Clinical Trials & Cancer Treatment Evaluating Cancer Treatment Claims FAQ Health & Wellness immunotherapy Integrative Oncology Insights Non-Chemo Cancer Treatments

How are newer cancer treatments different from traditional chemotherapy?

Newer cancer treatments, including targeted therapies and immunotherapies, attack cancer cells more precisely than traditional chemotherapy, which affects all rapidly dividing cells. These innovative approaches often result in fewer side effects and improved survival rates for some cancers. Treatment plans may combine old and new methods for optimal outcomes.